June 7, 2021 — Edwards Lifesciences recently announced that clinical results from the company's transcatheter mitral and tricuspid programs, presented as part of the late-breaking clinical trials...
EuroPCR
EuroPCR is the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and a world-leading course in interventional cardiovascular medicine. The event attracts more than 11,000 participants. Learn more about this conference at www.pcronline.com.
-
-
May 26, 2021 — Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress for the updated...
-
May 5, 2020 — The large European interventional cardiology conference EuroPCR has been cancelled due to the contenting containment efforts...
-
June 11, 2019 — Abbott recently announced positive late-breaking data from its TRILUMINATE study...
Blog | Structural Heart | June 08, 2021
It is brutal and very expensive to bring a new transcatheter valve to market. Boston Scientific invested vast amounts...
The 30-day outcomes from the TRISCEND study of the transfemoral Evoque tricuspid valve replacement system demonstrated technical feasibility and an acceptable safety profile, along with improvements in tricuspid regurgitation (TR) and symptoms in patients with clinically significant TR.
News | Structural Heart | June 07, 2021
June 7, 2021 — Edwards Lifesciences recently announced that clinical results from the company's transcatheter mitral...
The Acurate neo2 TAVR valve design enhancements include a 60% larger outer sealing skirt to conform to challenging anatomies. This has minimized paravalvular leaks and imporved clinical outcomes compared to the previous-generation Acurate neo Aortic Valve System.
Feature | Structural Heart | May 26, 2021
May 26, 2021 — Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress for the updated...
News | EuroPCR | May 05, 2020
May 5, 2020 — The large European interventional cardiology conference EuroPCR has been cancelled due to the contenting...
News | Heart Valve Technology | June 11, 2019
June 11, 2019 — Abbott recently announced positive late-breaking data from its TRILUMINATE study of the company's...
News | Hypertension | June 04, 2019
June 4, 2019 — Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato I...
News | Robotic Systems | May 28, 2019
May 28, 2019 — Corindus Vascular Robotics Inc. announced its CorPath GRX System was successfully used to perform a live...
News | CT Angiography (CTA) | May 28, 2019
May 28, 2019 — New data demonstrated that use of the investigational HeartFlow Planner, a real-time, non-invasive...
News | Renal Denervation | May 23, 2019
May 23, 2019 – Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical...
News | Heart Valve Technology | May 22, 2019
May 22, 2019 — Edwards Lifesciences Corp. announced strategic clinical and regulatory milestones for its Edwards Pascal...
Technology | Intravascular Imaging | May 20, 2019
May 20, 2019 — Philips announced the launch of the new IntraSight interventional applications platform. The secure,...
News | Atrial Fibrillation | May 15, 2019 | Dave Fornell, Editor
May 15, 2019 — Renal artery denervation (RDN) was found to be safe when employed with pulmonary vein isolation (PVI) to...
Feature | EuroPCR | May 10, 2019
May 10, 2019 — Here is the list of the late-breaking hot line studies being presented at the 2019 EuroPCR...
News | Heart Valve Technology | June 01, 2018
June 1, 2018 – Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with...
News | Renal Denervation | May 30, 2018
May 31, 2018 – ReCor Medical announced that the RADIANCE-HTN SOLO study met its primary efficacy endpoint and...
